Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases
NCT00242554
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Zoledronic acid
Sponsor
Novartis Pharmaceuticals